Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proton Pump Inhibitors | 5 | 2023 | 526 | 0.990 |
Why?
|
| Reperfusion Injury | 5 | 2015 | 1027 | 0.890 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 3 | 2018 | 24 | 0.850 |
Why?
|
| Cytochrome P-450 CYP3A | 4 | 2022 | 115 | 0.820 |
Why?
|
| Intestinal Absorption | 3 | 2014 | 420 | 0.790 |
Why?
|
| Cyclosporine | 3 | 2015 | 788 | 0.710 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2019 | 640 | 0.650 |
Why?
|
| Gout Suppressants | 1 | 2019 | 165 | 0.630 |
Why?
|
| Liver | 6 | 2019 | 7479 | 0.610 |
Why?
|
| Cimetidine | 2 | 2015 | 78 | 0.590 |
Why?
|
| Bronchial Neoplasms | 1 | 2017 | 112 | 0.570 |
Why?
|
| Folic Acid Antagonists | 1 | 2016 | 84 | 0.550 |
Why?
|
| Chromans | 2 | 2013 | 122 | 0.530 |
Why?
|
| Hematologic Tests | 1 | 2016 | 240 | 0.520 |
Why?
|
| Kidney Diseases | 3 | 2020 | 2146 | 0.510 |
Why?
|
| Pharmacokinetics | 1 | 2014 | 88 | 0.470 |
Why?
|
| Methotrexate | 2 | 2019 | 1726 | 0.470 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2013 | 52 | 0.460 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2015 | 436 | 0.450 |
Why?
|
| Tight Junctions | 2 | 2022 | 311 | 0.440 |
Why?
|
| Antiporters | 1 | 2013 | 277 | 0.410 |
Why?
|
| Kidney | 6 | 2020 | 7185 | 0.400 |
Why?
|
| Fetal Growth Retardation | 3 | 2019 | 566 | 0.380 |
Why?
|
| Rats, Wistar | 6 | 2020 | 1892 | 0.370 |
Why?
|
| Intestinal Mucosa | 3 | 2012 | 3038 | 0.360 |
Why?
|
| MicroRNAs | 3 | 2015 | 3750 | 0.340 |
Why?
|
| Intestine, Small | 2 | 2012 | 1240 | 0.320 |
Why?
|
| Hydrogen Peroxide | 3 | 2019 | 730 | 0.320 |
Why?
|
| Liver Circulation | 1 | 2008 | 164 | 0.320 |
Why?
|
| Carrier Proteins | 2 | 2014 | 5021 | 0.320 |
Why?
|
| Lymphoma | 1 | 2017 | 1875 | 0.310 |
Why?
|
| Copper | 3 | 2020 | 366 | 0.310 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3706 | 0.290 |
Why?
|
| Kidney Function Tests | 2 | 2019 | 684 | 0.270 |
Why?
|
| Sarcoma | 1 | 2017 | 1898 | 0.260 |
Why?
|
| Oxidative Stress | 3 | 2020 | 3082 | 0.260 |
Why?
|
| Carcinoma | 1 | 2017 | 2375 | 0.260 |
Why?
|
| Pre-Eclampsia | 3 | 2019 | 1200 | 0.260 |
Why?
|
| Biopsy | 1 | 2017 | 6750 | 0.260 |
Why?
|
| Intestines | 2 | 2022 | 1923 | 0.250 |
Why?
|
| Vasodilator Agents | 2 | 2019 | 974 | 0.250 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2019 | 690 | 0.250 |
Why?
|
| Intestinal Diseases | 1 | 2009 | 531 | 0.240 |
Why?
|
| Thymine | 1 | 2024 | 68 | 0.240 |
Why?
|
| Aflatoxin B1 | 1 | 2022 | 18 | 0.220 |
Why?
|
| Cisplatin | 2 | 2020 | 1662 | 0.210 |
Why?
|
| Pyrrolidines | 1 | 2024 | 341 | 0.200 |
Why?
|
| Caco-2 Cells | 3 | 2022 | 388 | 0.200 |
Why?
|
| Doxorubicin | 2 | 2018 | 2234 | 0.200 |
Why?
|
| Idarubicin | 1 | 2020 | 62 | 0.190 |
Why?
|
| Liver Diseases | 1 | 2009 | 1253 | 0.190 |
Why?
|
| Frontotemporal Dementia | 1 | 2024 | 248 | 0.190 |
Why?
|
| Rats | 8 | 2015 | 24250 | 0.190 |
Why?
|
| DNA Damage | 3 | 2020 | 2429 | 0.190 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 2 | 2019 | 101 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11524 | 0.180 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3690 | 0.180 |
Why?
|
| Aclarubicin | 1 | 2019 | 12 | 0.180 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4204 | 0.170 |
Why?
|
| Pregnancy, Animal | 1 | 2019 | 134 | 0.170 |
Why?
|
| Antihypertensive Agents | 3 | 2021 | 2047 | 0.170 |
Why?
|
| Protective Agents | 1 | 2020 | 156 | 0.170 |
Why?
|
| Colonic Neoplasms | 2 | 2024 | 2542 | 0.170 |
Why?
|
| Melanoma | 1 | 2017 | 5508 | 0.160 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2018 | 70 | 0.160 |
Why?
|
| Anthracyclines | 1 | 2020 | 288 | 0.160 |
Why?
|
| Drug Synergism | 2 | 2019 | 1794 | 0.160 |
Why?
|
| Liver Function Tests | 1 | 2019 | 529 | 0.160 |
Why?
|
| Enoxaparin | 1 | 2020 | 377 | 0.160 |
Why?
|
| Fetal Heart | 1 | 2019 | 276 | 0.160 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2023 | 685 | 0.160 |
Why?
|
| Carcinoma, Embryonal | 1 | 2017 | 38 | 0.150 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2017 | 254 | 0.150 |
Why?
|
| Tonsillar Neoplasms | 1 | 2017 | 51 | 0.150 |
Why?
|
| Tacrolimus | 1 | 2020 | 743 | 0.150 |
Why?
|
| Tomography | 1 | 2019 | 389 | 0.140 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 13691 | 0.140 |
Why?
|
| Living Donors | 1 | 2020 | 621 | 0.140 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2017 | 236 | 0.140 |
Why?
|
| Pyridones | 1 | 2020 | 711 | 0.130 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 4251 | 0.130 |
Why?
|
| Apoptosis | 3 | 2019 | 9718 | 0.130 |
Why?
|
| Thymoma | 1 | 2017 | 186 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2013 | 3000 | 0.130 |
Why?
|
| Uterus | 1 | 2019 | 711 | 0.130 |
Why?
|
| Drug Interactions | 2 | 2018 | 1460 | 0.130 |
Why?
|
| Thymus Neoplasms | 1 | 2017 | 268 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 820 | 0.120 |
Why?
|
| Rectal Neoplasms | 1 | 2024 | 1205 | 0.120 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1127 | 0.120 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 6773 | 0.120 |
Why?
|
| Male | 19 | 2021 | 349776 | 0.120 |
Why?
|
| Retrospective Studies | 8 | 2024 | 77410 | 0.110 |
Why?
|
| Cell Line | 3 | 2019 | 15993 | 0.110 |
Why?
|
| Heparin | 1 | 2020 | 1637 | 0.110 |
Why?
|
| Carboplatin | 1 | 2016 | 801 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2018 | 1185 | 0.110 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 477 | 0.110 |
Why?
|
| Skin Diseases | 1 | 2021 | 1066 | 0.110 |
Why?
|
| Glutathione | 2 | 2012 | 590 | 0.110 |
Why?
|
| Light | 1 | 2019 | 1365 | 0.110 |
Why?
|
| Malondialdehyde | 1 | 2012 | 105 | 0.110 |
Why?
|
| Temperature | 1 | 2019 | 2202 | 0.110 |
Why?
|
| Fluorouracil | 1 | 2017 | 1619 | 0.100 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 1176 | 0.100 |
Why?
|
| Drug Therapy | 1 | 2015 | 496 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2014 | 419 | 0.100 |
Why?
|
| Animals | 15 | 2020 | 168660 | 0.100 |
Why?
|
| Antioxidants | 2 | 2012 | 1658 | 0.100 |
Why?
|
| Pyrrolidinones | 1 | 2011 | 117 | 0.100 |
Why?
|
| Glucuronosyltransferase | 1 | 2011 | 128 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2021 | 10251 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 1903 | 0.100 |
Why?
|
| Liver Transplantation | 2 | 2015 | 2119 | 0.090 |
Why?
|
| Middle Aged | 10 | 2021 | 213241 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3208 | 0.090 |
Why?
|
| Humans | 28 | 2024 | 743811 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 560 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 513 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2073 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2020 | 1970 | 0.090 |
Why?
|
| Bile Acids and Salts | 1 | 2012 | 368 | 0.090 |
Why?
|
| Depsipeptides | 1 | 2010 | 94 | 0.090 |
Why?
|
| Medication Adherence | 1 | 2021 | 2063 | 0.090 |
Why?
|
| Cell Survival | 1 | 2019 | 5881 | 0.090 |
Why?
|
| Triglycerides | 1 | 2017 | 2453 | 0.090 |
Why?
|
| Aged | 9 | 2021 | 163178 | 0.090 |
Why?
|
| Biological Transport | 1 | 2014 | 2119 | 0.090 |
Why?
|
| Adult | 11 | 2022 | 213889 | 0.080 |
Why?
|
| Blood Pressure | 3 | 2021 | 8551 | 0.080 |
Why?
|
| Female | 15 | 2022 | 380020 | 0.080 |
Why?
|
| Hydroxylation | 1 | 2008 | 141 | 0.080 |
Why?
|
| Microsomes, Liver | 1 | 2008 | 174 | 0.080 |
Why?
|
| Ketoconazole | 1 | 2008 | 95 | 0.080 |
Why?
|
| Microsomes | 1 | 2008 | 257 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 57744 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2012 | 2327 | 0.080 |
Why?
|
| Biological Availability | 1 | 2008 | 397 | 0.080 |
Why?
|
| Bile | 1 | 2008 | 299 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 18027 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1213 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2012 | 13028 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3660 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2020 | 2077 | 0.070 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 1585 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 3794 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2015 | 2266 | 0.070 |
Why?
|
| Sesamum | 1 | 2006 | 16 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2012 | 3912 | 0.070 |
Why?
|
| Hypertension | 3 | 2021 | 8480 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6539 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2021 | 5100 | 0.070 |
Why?
|
| Dioxoles | 1 | 2006 | 104 | 0.070 |
Why?
|
| Lignans | 1 | 2006 | 81 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2020 | 4599 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 1743 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14714 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 789 | 0.060 |
Why?
|
| Collagen | 1 | 2013 | 2681 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 1968 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2008 | 1654 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 365 | 0.060 |
Why?
|
| Trifluridine | 1 | 2024 | 29 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2017 | 3057 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 689 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2736 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16674 | 0.050 |
Why?
|
| Uracil | 1 | 2024 | 165 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 20827 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2017 | 3142 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 7729 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 1714 | 0.050 |
Why?
|
| Vasodilation | 1 | 2006 | 944 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 4033 | 0.050 |
Why?
|
| Base Sequence | 1 | 2012 | 12798 | 0.050 |
Why?
|
| Doxycycline | 1 | 2022 | 326 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8385 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2021 | 258 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2006 | 1188 | 0.050 |
Why?
|
| Dextrans | 1 | 2022 | 595 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 1 | 2020 | 380 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 4260 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 5264 | 0.040 |
Why?
|
| Uterine Artery | 1 | 2019 | 36 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 393 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 18107 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6363 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 1516 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 56392 | 0.040 |
Why?
|
| Placenta | 2 | 2019 | 1699 | 0.040 |
Why?
|
| Blood Circulation | 1 | 2019 | 251 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2021 | 294 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2024 | 1958 | 0.040 |
Why?
|
| Testosterone | 1 | 2008 | 2297 | 0.040 |
Why?
|
| Phenanthrolines | 1 | 2018 | 55 | 0.040 |
Why?
|
| Organic Anion Transport Protein 1 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.040 |
Why?
|
| p-Aminohippuric Acid | 1 | 2018 | 36 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2018 | 211 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 40545 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 2018 | 166 | 0.040 |
Why?
|
| DNA, Circular | 1 | 2018 | 97 | 0.040 |
Why?
|
| Probenecid | 1 | 2018 | 76 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 595 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5691 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5230 | 0.040 |
Why?
|
| Cytochromes c | 1 | 2018 | 180 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 458 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 958 | 0.040 |
Why?
|
| Emulsions | 1 | 2017 | 156 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 8035 | 0.040 |
Why?
|
| Pregnancy | 4 | 2019 | 29140 | 0.040 |
Why?
|
| Superoxides | 1 | 2018 | 387 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2018 | 624 | 0.040 |
Why?
|
| Estrone | 1 | 2018 | 240 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 733 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 298 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 2017 | 408 | 0.040 |
Why?
|
| Heart Failure | 1 | 2019 | 10896 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2019 | 935 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 4152 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2018 | 23398 | 0.030 |
Why?
|
| Proteinuria | 1 | 2017 | 658 | 0.030 |
Why?
|
| Neoplasms | 2 | 2020 | 21675 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 72252 | 0.030 |
Why?
|
| HIV-1 | 1 | 2011 | 6939 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1894 | 0.030 |
Why?
|
| Emergency Treatment | 1 | 2017 | 517 | 0.030 |
Why?
|
| Mice | 5 | 2019 | 81154 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1114 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 2308 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 21824 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1237 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2183 | 0.030 |
Why?
|
| Fetal Development | 1 | 2017 | 767 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 13112 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 1695 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4931 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2013 | 271 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 2479 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2459 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6311 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14563 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2010 | 271 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 2984 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 1684 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 494 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2021 | 3117 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2006 | 195 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15281 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9731 | 0.020 |
Why?
|
| Plant Preparations | 1 | 2006 | 94 | 0.020 |
Why?
|
| HIV Infections | 1 | 2011 | 16715 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2006 | 683 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 4775 | 0.020 |
Why?
|
| Age Factors | 1 | 2021 | 18355 | 0.010 |
Why?
|
| Plant Proteins | 1 | 2006 | 364 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2013 | 4162 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10477 | 0.010 |
Why?
|
| Hospitalization | 1 | 2021 | 10259 | 0.010 |
Why?
|
| Brain | 2 | 2019 | 26345 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4326 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13869 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2006 | 2132 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 12944 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 8300 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13809 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9377 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63042 | 0.010 |
Why?
|
Concepts
(269)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_